Gene-knockout mice with abnormal epidermal and hair follicular development

Journal of Dermatological Science

Volumn 18, Issue 2, 1998, Pages 75-89

  Yamanishi, Kiyofumi ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Epidermis; Gene targeting; Hair follicles; Keratinocytes; Knockout mice; Skin development

Indexed keywords

DESMOGLEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR; FOLLISTATIN; GROWTH FACTOR RECEPTOR; HOMEODOMAIN PROTEIN; INTEGRIN; KERATIN; PLAKOGLOBIN; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR; STEROID RECEPTOR; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR; VITAMIN D RECEPTOR;

GENE TARGETING; HAIR FOLLICLE; KERATINOCYTE; KNOCKOUT MOUSE; MOUSE; MUTAGENESIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SKIN; SKIN DISEASE;

ANIMALS; EPIDERMIS; GENE EXPRESSION REGULATION; HAIR FOLLICLE; MICE; MICE, KNOCKOUT; SKIN; SKIN ABNORMALITIES; SKIN PHYSIOLOGY;

EID: 0032213008     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-1811(98)00040-1     Document Type: Review

References (108)

1. Mansour S.L., Thomas K.R., Deng C.X., Capecchi M.R. Introduction of a lacZ reporter gene into the mouse int-2 locus by homologous recombination. Proc Natl Acad Sci USA. 87:1990;7688-7692.
2. Todaro G.J., Rose T.M., Spooner C.E., Shoyab M., Plowman G.D. Cellular and viral ligands that interact with the EGF receptor. Semin Cancer Biol. 1:1990;257-263.
3. Akiyama M., Smith L.T., Holbrook K.A. Growth factor and growth factor receptor localization in the hair follicle bulge and associated tissue in human fetus. J Invest Dermatol. 106:1996;391-396.
4. Lynch S.E., Colvin R.B., Antoniades H.N. Growth factors in wound healing. Single and synergistic effects on partial thickness porcine skin wounds. J Clin Invest. 84:1998;640-646.
5. Luetteke N.C., Wiu T.-H., Peiffer R.L., Oliver P., Smithies O., Lee D.C. TGFα deficiency regulates in hair follicle and eye abnormalities in targeted and waved-1 mice. Cell. 73:1993;263-278.
6. Crew F.A. Waved: an autosomal recessive coat form character in the mouse. J Genet. 27:1933;95-96.
7. Massagué J., Pandiella A. Membrane-anchored growth factors. Ann Rev Biochem. 62:1993;515-541.
8. 125I]epidermal growth factor binding and receptor distribution in psoriasis. J Invest Dermatol. 86:1986;260-265.
9. Threadgill M.D., Dlugosz A.A., Hansen L.A., Tennenbaum T., Lichti U., Yee D., LaMantia C., Mourton T., Herrup K., Harris R.C., Barnard J.A., Yuspa S.H., Coffey R.J., Magnuson T. Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science. 269:1995;230-233.
10. Sibilia M., Wagner E.F. Strain-dependent epithelial defects in mice lacking the EGF receptor. Science. 269:1995;234-237.
11. Miettinen P.J., Berger J.E., Meneses J., Phung Y., Pedersen R.A., Werb Z., Derynck R. Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor. Nature. 376:1995;337-341.
12. McKay I.J., Lewis J., Lumsden A. The role of FGF-3 in early inner ear development: an analysis in normal and kreisler mutant mice. Dev Biol. 174:1996;370-378.
13. Feldman B., Poueymirou W., Papaioannou V.E., DeChiara T.M., Goldfarb M. Requirement of FGF-4 for postimplantation mouse development. Science. 267:1995;246-249.
14. Floss T., Arnold H.H., Braun T. A role for FGF-6 in skeletal muscle regeneration. Genes Dev. 11:1997;2040-2051.
15. Zhou M., Sutliff R.L., Paul R.J., Lorenz J.N., Hoying J.B., Haudenschild C.C., Yin M., Coffin J.D., Kong L., Kranias E.G., Luo W., Boivin G.P., Duffy J.J., Pawlowski S.A., Doetschman T. Fibroblast growth factor 2 control of vascular tone. Nat Med. 4:1998;201-207.
16. Ortega S., Ittmann M., Tsang S.H., Ehrlich M., Basilico C. Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2. Proc Natl Acad Sci USA. 95:1998;5672-5677.
17. Haub O., Goldfarb M. Expression of the fibroblast growth factor-5 gene in the mouse embryo. Development. 112:1991;397-406.
18. Haub O., Drucker B., Goldfarb M. Expression of the murine fibroblast growth factor 5 gene in the adult central nervous system. Proc Natl Acad Sci USA. 87:1990;8022-8026.
19. Hébert J.M., Rosenquist T., Götz J., Martin G.R. FGF5 as a regulator of the hair growth cycle: evidence from targeted and spontaneous mutations. Cell. 78:1994;1017-1025.
20. Rubin J.S., Bottaro D.P., Chedid M., Miki T., Ron D., Cunha G.R., Finch P.W. Keratinocyte growth factor as a cytokine that mediates mesenchymal-epithelial interaction. EXS. 74:1995;191-214.
21. Guo L., Yu Q.-C., Fuchs E. Targeting expression of keratinocyte growth factor to keratinocytes elicits striking changes in epithelial differentiation in transgenic mice. EMBO J. 12:1993;973-986.
22. Guo L.F., Degenstein L., Fuchs E. Keratinocyte growth factor is required for hair development but not for wound healing. Genes Dev. 10:1996;165-175.
23. Michel U., Farnworth P., Findlay J.K. Follistatins: more than follicle-stimulating hormone suppressing proteins. Mol Cell Endocrinol. 91:1993;1-11.
24. Matzuk M.M., Lu N., Vogel H., Sellheyer K., Roop D.R., Bradley A. Multiple defects and perinatal death in mice deficient in follistatin. Nature. 374:1995;360-363.
25. Matzuk M.M., Kumar T.R., Bradley A. Different phenotypes for mice deficient in either activins or activin receptor type II. Nature. 374:1995;356-360.
26. 1 in the epidermis of transgenic mice. Proc Natl Acad Sci USA. 90:1993;5237-5241.
27. Kingsley D.M., Bland A.E., Grubber J.M., Marker P.C., Russell L.B., Copeland N.G., Jenkins N.A. The mouse short ear skeletal morphogenesis locus is associated with defects in a bone morphogenetic member of the TGFβ superfamily. Cell. 71:1992;399-410.
28. Georges-Labouesse E., Messaddeq N., Yehia G., Cadalbert L., Dierich A., Le Meur M. Absence of integrin α6 leads to epidermolysis bullosa and neonatal death in mice. Nat Genet. 13:1996;370-373.
29. 4 integrin is required for hemidesmosome formation, cell adhesion and cell survival. J Cell Biol. 134:1996;559-572.
30. Van der Neut R., Krimpenfort P., Calafat J., Niessen C.M., Sonnenberg A. Epithelial detachment due to absence of hemidesmosomes in integrin β4 null mice. Nat Genet. 13:1996;366-369.
31. Vidal F., Aberdam D., Miquel C., Christiano A.M., Pulkkinen L., Uitto J., Ortonne J.-P., Meneguzzi G. Integrin β4 mutations associated with junctional epidermolysis bullosa with pyloric atresia. Nat Genet. 10:1995;229-234.
32. 6 integrin mutation in junctional epidermolysis bullosa with congenital duodenal atresia. Hum Mol Genet. 6:1997;669-674.
33. Schwarz M.A., Owaribe K., Kartenbeck J., Franke W.W. Desmosomes and hemidesmosomes: constitutive molecular components. Ann Rev Cell Biol. 6:1990;461-491.
34. Amagai M., Koch P.J., Nishikawa T., Stanley J.R. Pemphigus vulgaris antigen (Desmoglein 3) is localized in the lower epidermis, the site of blister formation in patients. J Invest Dermatol. 106:1996;351-355.
35. Schafer S., Stumpp S., Franke W.W. Immunological identification and characterization of the desmosomal cadherin Dsg2 in coupled and uncoupled epithelial cells and in human tissues. Differentiation. 60:1996;99-108.
36. Stanley J.R. Cell adhesion molecules as targets of autoantibodies in pemphigus and pemphigoid, bullous diseases due to defective epidermal cell adhesion. Adv Immunol. 53:1993;291-325.
37. Allen E., Yu Q.C., Fuchs E. Mice expressing a mutant desmosomal cadherin exhibit abnormalities in desmosomes, proliferation, and epidermal differentiation. J Cell Biol. 133:1996;1367-1382.
38. Koch P.J., Mahoney M.G., Ishikawa H., Pulkkinen L., Uitto J., Shultz L., Murphy G.F., Whitaker-Menezes D., Stanley J.R. Targeted disruption of the pemphigus vulgaris antigen (Desmoglein 3) gene in mice causes loss of keratinocyte cell adhesion with a phenotype similar to pemphigus vulgaris. J Cell Biol. 137:1997;1091-1102.
39. Sundberg JP. The balding (bal) mutation, chromosome 18. In: Sundberg JP, editor. Handbook of Mouse Mutations with Skin and Hair Abnormalities: Animal Models and Biomedical Tools. Boca Raton, FL: CRC Press, 1994:187-191.
40. Peifer M. Cell adhesion and signal trasduction: the armadillo connection. Trends Cell Biol. 5:1995;224-229.
41. Peifer M., Wieschaus E. The segment polarity gene armadillo encodes a functionally modular protein that is the Drosophila homolog of human plakoglobin. Cell. 63:1990;1167-1176.
42. Behrens J., Von Kries J.P., Kühl M., Bruhn L., Wedlich D., Grosschedl R., Birchmeier W. Functional interaction of β-catenin with the transcription factor LEF-1. Nature. 382:1996;638-642.
43. Ruiz P., Brinkmann V., Ledermann B., Behrend M., Grund C., Thalhammer C., Vogel F., Birchmeier C., Günthert U., Franke W.W. Targeted mutation of plakoglobin in mice reveals essential function of desmosomes in the embryonic heart. J Cell Biol. 135:1996;215-225.
44. Guo L., Degenstein L., Dowling J., Yu Q.-C., Wollmann R., Perman B., Fuchs E. Gene targeting of BPAG1: abnormalities in mechanical strength and cell migration in stratified epithelia and neurologic degeneration. Cell. 81:1995;233-243.
45. Brown A., Bernier G., Mathieu M., Rossant J., Kothary R. The mouse dystonia musculorum gene is a neural isoform of bullous pemphigoid antigen 1. Nat Genet. 10:1995;301-306.
46. Hieda Y., Nishizawa Y., Uematsu J., Owaribe K. Identification of a new hemidesmosomal protein, HD1: a major, high molecular mass component of isolated hemidesmosomes. J Cell Biol. 116:1992;1497-1506.
47. Wiche G., Becker B., Luber K., Weitzer G., Castanon M.J., Hauptmann R., Stratowa C., Stewart M. Cloning and sequencing of rat plectin indicates a 466-kD polypeptide chain with a three-domain structure based on a central a-helical coiled coil. J Cell Biol. 114:1991;83-99.
48. McLean W.H.I., Pulkkinen L., Smith F.J.D., Rugg E.L., Lane E.B., Bullrich F., Burgeson R.E., Amano S., Hudson D.L., Owaribe K., McGrath J.A., McMillan J.R., Eady R.A.J., Leigh I.M., Christiano A.M., Uitto J. Loss of plectin causes epidermolysis bullosa with muscular dystrophy: cDNA cloning and genomic organization. Genes Dev. 10:1996;1724-1735.
49. Wiche G., Gromov D., Donovan A., Castanon M.J., Fuchs E. Expression of plectin mutant cDNA in cultured cells indicates a role of COOH-terminal domain in intermediate filament association. J Cell Biol. 121:1993;607-619.
50. Smith F.J.D., Eady R.A.J., Leigh I.M., McMillan J.R., Rugg E.L., Kelsell D.P., Bryant S.P., Spurr N.K., Geddes J.F., Kirtschig G., Milana G., De Bono A.G., Owaribe K., Wiche G., Pulkkinen L., Uitto J., McLean W.H.I., Lane E.B. Plectin deficiency results in muscular dystrophy with epidermolysis bullosa. Nat Genet. 13:1996;450-457.
51. Andrä K., Lassmann H., Bittner R., Shorny S., Fässler R., Propst F., Wiche G. Targeted inactivation of plectin reveals essential function in maintaining the integrity of skin, muscle, and heart cytoarchitecture. Genes Dev. 11:1997;3143-3156.
52. Fisher G.J., Voorhees J.J. Molecular mechanisms of retinoid actions in skin. FASEB J. 10:1996;1002-1013.
53. Li E., Sucov H.M., Lee K.F., Evans R.M., Jaenisch R. Normal development and growth of mice carrying a targeted disruption of the a1 retinoic acid receptor gene. Proc Natl Acad Sci USA. 15:1993;1590-1594.
54. Lohnes D., Kastner P., Dierich A., Mark M., LeMeur M., Chambon P. Function of retinoic acid receptor γ in the mouse. Cell. 73:1993;643-658.
55. Kastner P., Grondona J.M., Mark M., Gansmuller A., LeMeur M., Decimo D., Vonesch J.L., Dolle P., Chambon P. Genetic analysis of RXRα developmental function: convergence of RXR and RAR signaling pathways in heart and eye morphogenesis. Cell. 78:1994;987-1003.
56. Saitou M., Sugai S., Tanaka T., Shimouchi K., Fuchs E., Narumiya S., Kakizuka A. Inhibition of skin development by targeted expression of a dominant-negative retinoic acid receptor. Nature. 374:1995;159-162.
57. Imakado S., Bickenbach J.R., Bundman D.S., Rothnagel J.A., Attar P.S., Wang X.-J., Walczak V.R., Wisniewski S., Pote J., Gordon J.S., Heyman R.A., Evans R.M., Roop D.R. Targeting expression of a dominant-negative retinoic acid receptor mutant in the epidermis of transgenic mice results in loss of barrier function. Genes Dev. 9:1995;317-329.
58. Yoshizawa T., Handa Y., Uematsu Y., Takeda S., Sekine K., Yoshihara Y., Kawakami T., Arioka K., Sato H., Uchiyama Y., Masushige S., Fukamizu A., Matsumoto T., Kato S. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat Genet. 16:1997;391-396.
59. Hughes M.R., Malloy P.J., Kieback D.G., Kesterson R.A., Pike J.W., Feldman D., O'Malley B.W. Point mutations in the human vitamin D receptor gene associated with hypocalcemic rickets. Science. 242:1988;1702-1705.
60. 3 resistant rickets in seven related families. J Clin Invest. 86:1990;2071-2079.
61. Wegner M., Drolet D.W., Rosenfeld M.G. POU-domain proteins: structure and function of developmental regulators. Curr Opin Cell Biol. 5:1993;488-498.
62. Yukawa K., Yasui T., Yamamoto A., Shiku H., Kishimoto T., Kikutani H. Epoc-1: a POU-domain gene expressed in murine epidermal basal cells and thymic stromal cells. Gene. 133:1993;163-169.
63. Andersen B., Schonemann M.D., Flynn S.E., Pearse R.V. II, Singh H., Rosenfeld M.G. Skn-1a and Skn-1i: two functionally distinct Oct-2-related factors expressed in epidermis. Science. 260:1993;78-82.
64. Fischer D.F., Gibbs S., van de Putte P., Backendorf C. Interdependent transcription control elements regulate the expression of the SPRR2A gene during keratinocyte terminal differentiation. Mol Cell Biol. 16:1996;5365-5374.
65. Welter J.F., Gali H., Crish J.F., Eckert R.L. Regulation of human involucrin promoter activity by POU domain proteins. J Biol Chem. 271:1996;14727-14733.
66. Andersen B., Weinberg W.C., Rennekampff O., McEvilly R.J., Bermingham J.R. Jr., Hooshmand F., Vasilyev V., Hansbrough J.F., Pittelkow M.R., Yuspa S.H., Rosenfeld M.G. Functions of the POU domain genes Skn-1a/i and Tst-1/Oct-6/SCIP in epidermal differentiation. Genes Dev. 11:1997;1873-1884.
67. Yukawa K., Butz K., Yasui T., Kikutani H., Hoppe-Seyler F. Regulation of human papillomavirus transcription by the differentiation-dependent epithelial factor Epoc-1/skn-1a. J Virol. 70:1996;10-16.
68. Faus I., Hsu H.-J., Fuchs E. Oct-6: a regulator of keratinocyte gene expression in stratified squamous epithelia. Mol Cell Biol. 14:1994;3263-3275.
69. Nehls M., Pfeife R.D., Schorpp M., Hedrich H., Boehm T. New member of the winged-helix protein family disrupted in mouse and rat nude mutations. Nature. 372:1994;103-107.
70. Lai E., Clark K.L., Burley S.K., Darnell J.E. Jr. Hepatocyte nuclear factor 3/fork head or "winged helix" proteins: a family of transcription factors of diverse biologic function. Proc Natl Acad Sci USA. 90:1993;10421-40423.
71. Nehls M., Kyewski B., Messerle M., Waldschutz R., Schuddekopf K., Smith A.J., Boehm T. Two genetically separable steps in the differentiation of thymic epithelium. Science. 272:1996;886-889.
72. Stoye J.P., Fenner S., Greenoak G.E., Moran C., Coffin J.M. Role of endogenous retroviruses as mutagens: the hairless mutation of mice. Cell. 54:1988;383-391.
73. Cachon-Gonzalez M.B., Fenner S., Coffin J.M., Moran C., Best S., Stoye J.P. Structure and expression of the hairless gene of mice. Proc Natl Acad Sci USA. 91:1994;7717-7721.
74. Ahmad W., Faiyaz ul Haque M., Brancolini V., Tsou H.C., ul Haque S., Lam H., Aita V.M., Owen J., deBlaquiere M., Frank J., Cserhalmi-Friedman P.B., Leask A., McGrath J.A., Peacocke M., Ahmad M., Ott J., Christiano A.M. Alopecia universalis associated with a mutation in the human hairless gene. Science. 279:1998;720-724.
75. McGinnis W., Krumlauf R. Homeobox genes and axial patterning. Cell. 68:1992;283-302.
76. Godwin A.R., Capecchi M.R. Hoxc13 mutant mice lack external hair. Genes Dev. 12:1998;11-20.
77. Cohen S.M., Brönner G., Küttner F., Jürgens G., Jäckle H. Distal-less encodes a homoeodomain protein required for limb development in Drosophila. Nature. 338:1989;432-434.
78. Morasso M.I., Jamrich M., Sargent T.D. The homeodomain gene Xenopus Distal-less-like-2 (Xdll-2) is regulated by a conserved mechanism in amphibian and mammalian epidermis. Dev Biol. 162:1994;267-276.
79. Morasso M.I., Markova N.G., Sargent T.D. Regulation of epidermal differentiation by a Distal-less homeodomain gene. J Cell Biol. 135:1996;1879-1887.
80. Fuchs E., Cleveland D.W. A structural scaffolding of intermediate filaments in health and disease. Science. 279:1998;514-519.
81. Fuchs E., Coulombe P.A. Of mice and men: genetic skin diseases of keratin. Cell. 69:1992;899-902.
82. Vassar R., Coulombe P.A., Degenstein L., Albers K., Fuchs E. Mutant keratin expression in transgenic mice causes marked abnormalities resembling a human genetic skin disease. Cell. 64:1991;365-380.
83. Fuchs E., Esteves R.A., Coulombe P.A. Transgenic mice expressing a mutant keratin 10 gene reveal the likely genetic basis for epidermolytic hyperkeratosis. Proc Natl Acad Sci USA. 89:1992;6906-6910.
84. Bickenbach J.R., Longley M.A., Bundman D.S., Dominey A.M., Bowden P.E., Rothnagel J.A., Roop D.R. A transgenic mouse model that recapitulates the clinical features of both neonatal and adult forms of the skin disease epidermolytic hyperkeratosis. Differentiation. 61:1996;129-139.
85. Lloyd C., Yu Q.-C., Cheng J., Turksen K., Degenstein L., Hutton E., Fuchs E. The basal keratin network of stratified squamous epithelia: defining K15 function in the absence of K14. J Cell Biol. 129:1995;1329-1344.
86. Chan Y.-M., Anton-Lamprecht I., Yu Q.-C., Jäckel A., Zabel B., Ernst J.-P., Fuchs E. A human keratin 14 "knockout": the absence of K14 leads to severe epidermolysis bullosa simplex and a function for an intermediate filament protein. Genes Dev. 8:1994;2574-2587.
87. Porter R.M., Leitgeb S., Melton D.W., Swensson O., Eady R.A.J., Magin T.M. Gene targeting at the mouse cytokeratin 10 locus: severe skin fragility and changes of cytokeratin expression in the epidermis. J Cell Biol. 132:1996;925-936.
88. Steinert P.M., Marekov L.N. The proteins elafin, filaggrin, keratin intermediate filaments, loricrin, and small proline-rich proteins 1 and 2 are isodipeptide cross-linked components of the human epidermal cornified cell envelope. J Biol Chem. 270:1995;17702-17711.
89. Jarnik M., Simon M.N., Steven A.C. Cornified cell envelope assembly: a model based on electron microscopic determinations of thickness and projected density. J Cell Sci. 111:1998;1051-1060.
90. Nonomura K., Yamanishi K., Hosokawa Y., Doi H., Hirano J., Fukushima S., Yasuno H. Localization of transglutaminase 1 mRNA in normal and psoriatic epidermis by non-radioactive in situ hybridization. Br J Dermatol. 128:1993;23-28.
91. Michel S., Bernerd F., Jetten A.M., Floyd E.E., Shroot B., Reichert U. Expression of keratinocyte transglutaminase mRNA revealed by in situ hybridization. J Invest Dermatol. 98:1992;364-368.
92. Kim S.-Y., Chung S.-I., Yoneda K., Steinert P.M. Expression of transglutaminase 1 in human epidermis. J Invest Dermatol. 104:1995;211-217.
93. Kim I.-G., McBride O.W., Wang M., Kim S.-Y., Idler W.W., Steinert P.M. Structure and organization of the human transglutaminase 1 gene. J Biol Chem. 267:1992;7710-7717.
94. Bianchi L., Farrace M.G., Nini G., Piacentini M. Abnormal bcl-2 and "tissue" transglutaminase expression in psoriatic skin. J Invest Dermatol. 103:1994;829-833.
95. Kim I.-G., Gorman J.J., Park S.-C., Chung S.-I., Steinert P.M. The deduced sequence of the novel protransglutaminase E (TGase 3) of human and mouse. J Biol Chem. 268:1993;12682-12690.
96. Aeschlimann D., Koeller M.K., Allen-Hoffmann B.L., Mosher D.F. Isolation of a cDNA encoding a novel member of the transglutaminase gene family from human keratinocytes - detection and identification of transglutaminase gene products based on reverse transcription polymerase chain reaction with degenerate primers. J Biol Chem. 273:1998;3452-3460.
97. Matsuki M., Yamashita F., Ishida-Yamamoto A., Yamada K., Kinoshita C., Fushiki S., Ueda E., Morishima Y., Tabata K., Yasuno H., Hashida M., Iizuka H., Ikawa M., Okabe M., Kondoh G., Kinoshita T., Takeda J., Yamanishi K. Defective stratum corneum and early neonatal death in mice lacking the gene for transglutaminase 1 (keratinocyte transglutaminase). Proc Natl Acad Sci USA. 95:1998;1044-1049.
98. Maestrini E., Monaco A.P., McGrath J.A., Ishida-Yamamoto A., Camisa C., Hovnanian A., Weeks D.E., Lathrop M., Uitto J., Christiano A.M. A molecular defect in loricrin, the major component of the cornified cell envelope, underlies Vohwinkel's syndrome. Nat Genet. 13:1996;70-77.
99. Korge B.P., Ishida-Yamamoto A., Pünter C., Dopping-Hepenstal P.J.C., Iizuka H., Stephenson A., Eady R.A.J., Munro C.S. Loricrin mutation in Vohwinkel's keratoderma is unique to the variant with ichthyosis. J Invest Dermatol. 109:1997;604-610.
100. Ishida-Yamamoto A., McGrath J.A., Lam H.M., Iizuka H., Friedman R.A., Christiano A.M. The molecular pathology of progressive symmetric erythrokeratoderma: a frameshift mutation in the loricrin gene and perturbations in the cornified cell envelope. Am J Hum Genet. 61:1997;581-589.
101. Yoneda K., Steinert P.M. Overexpression of human loricrin in transgenic mice produces a normal phenotype. Proc Natl Acad Sci USA. 90:1993;10754-10758.
102. Rajewsky K., Gu H., Kühn R., Betz U.A.K., Müller W., Roes J., Schwenk F. Conditional gene targeting. J Clin Invest. 98:1996;600-603.
103. Tarutani M., Itami S., Okabe M., Ikawa M., Tezuka T., Yoshikawa K., Kinoshita T., Takeda J. Tissue-specific knockout of the mouse Pig-a gene reveals important roles for GPI-anchored proteins in skin development. Proc Natl Acad Sci USA. 94:1997;7400-7405.
104. Miyata T., Takeda J., Iida Y., Yamada N., Inoue N., Takahashi M., Maeda K., Kitani T., Kinoshita T. The cloning of Pig-a, a component in the early step of GPI-anchor biosynthesis. Science. 259:1993;1318-1320.
105. Takeda J., Miyata T., Kawagoe K., Iida Y., Endo Y., Fujita T., Takahashi M., Kitani T., Kinoshita T. Deficiency of the GPI anchor caused by a somatic mutation of the Pig-a gene in paroxysmal nocturnal hemoglobinuria. Cell. 73:1993;703-711.
106. Metzger D., Clifford J., Chiba H., Chambon P. Conditional site-specific recombination in mammalian cells using a ligand-dependent chimeric Cre recombinase. Proc Natl Acad Sci USA. 92:1995;6991-6995.
107. Feil R., Brocard J., Mascrez B., LeMeur M., Metzger D., Chambon P. Ligand-activated site-specific recombination in mice. Proc Natl Acad Sci USA. 93:1996;10887-10890.
108. Brocard J., Warot X., Wendling O., Messaddeq N., Vonesch J.-L., Chambon P., Metzger D. Spatio-temporally controlled site-specific somatic mutagenesis in the mouse. Proc Natl Acad Sci USA. 94:1997;14559-14563.